These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6705421)

  • 1. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-induced changes in the plasma binding of basic drugs.
    Piafsky KM
    Clin Pharmacokinet; 1980; 5(3):246-62. PubMed ID: 6156048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding predictions in infants.
    McNamara PJ; Alcorn J
    AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver.
    Meijer DK; Van der Sluijs P
    Pharm Weekbl Sci; 1987 Apr; 9(2):65-74. PubMed ID: 3295762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
    Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.
    Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein binding of drugs in pregnancy and in neonates.
    Notarianni LJ
    Clin Pharmacokinet; 1990 Jan; 18(1):20-36. PubMed ID: 2178848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug protein binding and the nephrotic syndrome.
    Gugler R; Azarnoff DL
    Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free drug concentration monitoring in clinical practice. Rationale and current status.
    Svensson CK; Woodruff MN; Baxter JG; Lalka D
    Clin Pharmacokinet; 1986; 11(6):450-69. PubMed ID: 3542337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma binding of drugs in chronic renal failure].
    Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
    Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.
    Hill MD; Abramson FP
    Clin Pharmacokinet; 1988 Mar; 14(3):156-70. PubMed ID: 3286084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma protein binding of basic drugs.
    Routledge PA
    Br J Clin Pharmacol; 1986 Nov; 22(5):499-506. PubMed ID: 3790398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.
    Wood M; Wood AJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):522-6. PubMed ID: 7471620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.